Navigation Links
Securus Medical Group Raises $6.5M, Appoints New CEO

CLEVELAND, Oct. 29, 2013 /PRNewswire-USNewswire/ -- Securus Medical Group, Inc., a privately held medical device company, announced the initial closing of a $6.5 million Series B financing led by new investor 3X5 Special Opportunity Fund, and that Steven Girouard, PhD has been named President and Chief Executive Officer.  A medical device industry veteran, Steve has held executive leadership roles at Johnson & Johnson, Guidant Corporation, Cleveland Clinic and Oakwood Medical Investors.  Existing investor RiverVest Venture Partners, as well as the University of Michigan Investment in New Technology Startups (MINTS) program, also participated in the financing.  Securus plans to use Series B proceeds to further develop their Aurora™ thermographic mapping system, a proprietary thermal measurement device that is expected to have several clinical applications for temperature monitoring during energy-based surgical procedures.  As part of the financing, Nicholas Walrod, Principal of 3X5 Special Opportunity Fund, will join the Board of Directors. 


"We are enthusiastic in our support of Securus and we were delighted to attract Steve to lead the Company during this critical phase of development," said Walrod.  "We see an opportunity for several large medical device markets to benefit from Securus monitoring technology and Steve brings to Securus deep industry insights and a strong network in target markets for the Company." 

Securus plans to maintain its headquarters in Ohio on the campus of Cleveland Clinic's Global Cardiovascular Innovation Center, an early grant-based supporter of the Company.  The Company's 2011 Series A financing was led by RiverVest and included JumpStart and the University of Michigan.

3x5 Special Opportunity Fund, L.P. is a St. Louis and Portland-based, closed-end private investment fund focused primarily on direct investments in later-stage companies within the healthcare and clean-tech sectors. The fund closed in early 2013 at approximately $80 million in committed capital, which it expects to deploy over six portfolio investments.

RiverVest Venture Partners is a venture capital firm focused on identifying and shaping early stage life science companies to create significant shareholder value. With hands-on, high-level expertise and financial resources, RiverVest supports entrepreneurs by helping them achieve near-term objectives that position their companies for exit. For more information, please visit

SOURCE Securus Medical Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nonin Medical Appoints Richard J. Eagle Vice President of Sales
2. Solta Medical to Report Third Quarter 2013 Results and Host Conference Call on November 11, 2013
3. Utah Hospital Saves Money and the Environment by Treating Its Own Medical Waste on Site
4. Medical Imaging Equipment Market is Expected to Reach USD 35.35 Billion Globally in 2019: Transparency Market Research
5. Epiditi - "COOL THE JEWELS!" The Only Form-Fitting Scrotal Ice Pack on the Planet - Now A Medical Crowdfunding Project
6. Middle Peak Medical Raises an Additional $3M to Develop Novel Mitral Valve Technology
7. Aethlon Medical (AEMD) Note: Cancer Immunotherapy Article, Introduction to Dr. Douglas Taylor
8. Media Sourcerys Secure Mobile Workflow App Deployed by CCS Medical to Expedite Product Delivery to Patients
9. Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2013
10. Varian Medical Systems Schedules Fiscal Year End Review for Investors in New York
11. Boston Scientific Receives Prestigious 2013 Prix Galien Award For Best Medical Technology
Post Your Comments:
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... nuevo enfoque combina la inmunoterapia con la terapia fotodinámica ... Clinical Cancer Research . --> Clinical ...
(Date:11/26/2015)... 2015 --> --> ... to find optimal contrast weighting of MRI for patients ... signed a research agreement with SyntheticMR in order to use ... it is possible to generate multiple contrast images from a ... has left, thus making it possible to both fine tune ...
Breaking Medicine Technology:
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ProSidebar: ... in Final Cut Pro X. With ProSidebar: Fasion, video editors can easily add ... ProSidebar as a minimalist title opener. Utilize presets featuring self-animating drop zones, lines, ...
(Date:11/27/2015)... ... 27, 2015 , ... Consistent with the Radiology Business ... Better Radiology Marketing Programs meeting will showcase some of the best 2015 ... Caesars Palace in Las Vegas with a pre-conference session on a collaborative approach ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, ... interesting show that delves into an array of issues that are presently affecting Americans. ... from open dialogue, this show is changing the subjects consumers focus on, one episode ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... an innovative online platform for mental health and wellness consultation, has collaborated with ... partnership will bridge the knowledge gap experienced by parents and bring advice from ...
(Date:11/27/2015)... ... 2015 , ... The men and women on this list ... the country. They have overseen financial turnarounds, shown commitment to their community through ... as a whole through their advocacy and professional efforts. , Becker's Hospital Review ...
Breaking Medicine News(10 mins):